Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of $0.01, versus $0.09 reported last year. Revenue for the quarter came in at $2.2 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.